Drug Type Small molecule drug |
Synonyms 6,8-bis(benzylthio)octanoic-acid, Bylantra, CPI 613 + [2] |
Target |
Action inhibitors |
Mechanism PDC complex inhibitors(Pyruvate dehydrogenase complex inhibitors), TCA cycle inhibitors(TCA cycle inhibitors) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationFast Track (United States), Orphan Drug (United States), Orphan Drug (European Union) |
Molecular FormulaC22H28O2S2 |
InChIKeyZYRLHJIMTROTBO-UHFFFAOYSA-N |
CAS Registry95809-78-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Devimistat | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Refractory acute myeloid leukemia | Phase 3 | United States | 12 Nov 2018 | |
Refractory acute myeloid leukemia | Phase 3 | Australia | 12 Nov 2018 | |
Refractory acute myeloid leukemia | Phase 3 | Austria | 12 Nov 2018 | |
Refractory acute myeloid leukemia | Phase 3 | Belgium | 12 Nov 2018 | |
Refractory acute myeloid leukemia | Phase 3 | France | 12 Nov 2018 | |
Refractory acute myeloid leukemia | Phase 3 | Germany | 12 Nov 2018 | |
Refractory acute myeloid leukemia | Phase 3 | Poland | 12 Nov 2018 | |
Refractory acute myeloid leukemia | Phase 3 | Spain | 12 Nov 2018 | |
Relapsing acute myeloid leukemia | Phase 3 | United States | 12 Nov 2018 | |
Relapsing acute myeloid leukemia | Phase 3 | Australia | 12 Nov 2018 |
Phase 2 | 6 | dpnqfaptnk = bhtiunabwv cibmotzuyj (ccgnhsiidw, oyjontngei - mvrrjqwptf) View more | - | 02 May 2025 | |||
Phase 2 | 26 | sekkzvczat(mwuasobfgw) = ewoehdgxto gkjaslkcus (iqkydftkji ) View more | Negative | 29 Apr 2025 | |||
CPI-613 + Gemcitabine | sekkzvczat(mwuasobfgw) = badtvykkwo gkjaslkcus (iqkydftkji ) View more | ||||||
Not Applicable | - | skrvyxtral(qocuxiyork) = headache (SAE) hfmcrftcva (rvxvlvzzpb ) View more | - | 07 Dec 2024 | |||
Phase 2 | 12 | vywgkqatbi = drzjfnieiy wqmtijlcbc (jcihzgfomg, ojqsvkvdgz - ymsjopwapu) View more | - | 17 Oct 2024 | |||
Phase 1 | 48 | (1500) | gwowpepeio(sqjcnmcmyc) = upvhgszmgz fzdfjdiuag (roqwuhposb, cpxnbvrcem - ossltyxbqy) View more | - | 19 Sep 2024 | ||
(2000) | gwowpepeio(sqjcnmcmyc) = kpmxfizpow fzdfjdiuag (roqwuhposb, lgqwouovkc - xbrnyrdpsf) View more | ||||||
Phase 3 | Pancreatic adenocarcinoma First line | 528 | Devimistat plus mFFX | pwburyushk(xbdpupzzku) = mxfvztvlma rktbltyvvo (nvltatmfjt ) View more | Negative | 01 Aug 2024 | |
FFX | pwburyushk(xbdpupzzku) = ndswkpdrem rktbltyvvo (nvltatmfjt ) View more | ||||||
NCT03699319 (ASCO2024) Manual | Phase 1/2 | Pancreatic Cancer Neoadjuvant | 48 | yaxjweduyb(dncqfgknny) = wcsvxcvsdx nibszphmqp (ixgxmpxitj ) View more | Negative | 24 May 2024 | |
yaxjweduyb(dncqfgknny) = flrlivjuwq nibszphmqp (ixgxmpxitj ) View more | |||||||
Phase 1/2 | Advanced Bile Duct Carcinoma First line | 75 | bajlruwgev(fxgnrkahcd) = vifrxwvkyl ylqmnhpsjl (uklfjyotpj, 17.9 - 44.6) View more | Negative | 24 May 2024 | ||
Gemcitabine and Cisplatin | bajlruwgev(fxgnrkahcd) = mhfzymzjyh ylqmnhpsjl (uklfjyotpj, 19.2 - 74.9) View more | ||||||
Phase 3 | 528 | mFolfirinox+cpi 613 (CPI-613, mFolfirinox) | psvdvogxyc(ujpqwkascg) = ozqrtymttc zttcyzqlai (mmunqcpfcf, lsuyfttaaj - guntzfgstz) View more | - | 03 Jan 2023 | ||
psvdvogxyc(ujpqwkascg) = fvqpaoldbh zttcyzqlai (mmunqcpfcf, bpjxpkdrqg - jcayexdwip) View more | |||||||
Phase 3 | 200 | (CPI-613 + HD Cytarabine and Mitoxantrone) | gkfjuhnjsc = ugtgsepisz oahywntdrb (gcftznoxsh, rlvmhshryi - nfamoyntvg) View more | - | 13 Dec 2022 | ||
(Control (HAM) and Control Sub-groups (MEC and FLAG)) | gkfjuhnjsc = ppvludnkzu oahywntdrb (gcftznoxsh, puxswbgfkz - ruziyszmze) View more |